March 30, 2020

Rhythm Pharmaceuticals

Rhythm Pharmaceuticals Provides Updates on Leadership Transition and Business Operations

March 30, 2020

Rhythm Pharmaceuticals

Rhythm Pharmaceuticals Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Setmelanotide in POMC and LEPR Deficiency Obesities

March 30, 2020

MyoKardia

MyoKardia Announces Mavacamten Treatment Well Tolerated and Significantly Reduced Biomarkers of Cardiac Injury and Wall Stress in Non-Obstructive Hypertrophic Cardiomyopathy Patients

March 30, 2020

CytomX Therapeutics

CytomX Therapeutics Announces Milestone Achievement in AbbVie CD71 Partnership and Provides Update on Impact of COVID-19 on Clinical Stage Pipeline

March 30, 2020

Agios Pharmaceuticals

Agios Receives Positive Opinion on Orphan Drug Designation from the European Medicines Agency for Mitapivat in Pyruvate Kinase Deficiencyag

Load More

Sign up for weekly portfolio news.